National grant success for WA researcher

Curtin University researcher Associate Professor Hannah Moore has been awarded around $1.5 million from the National Health and Medical Research Council (NHMRC) Partnership Project funding scheme, made possible by a $1 million grant provided by the Future Health Research and Innovation (FHRI) Fund.
Professor Moore’s project aims to characterise Respiratory Syncytial Virus (RSV) epidemiology and dynamics, focusing on paediatric populations and high-risk groups.
Respiratory syncytial virus (RSV) is a leading cause of respiratory infections worldwide with a disproportionate burden in young children. Whilst two RSV immunisation therapeutics have shown promising results against severe RSV and are being licenced worldwide, evidence is required to support decisions around optimal use of these therapeutics, including whether to target high risk groups or all infants, and the timing of immunisation. Associate Professor Moore’s project will explore these questions through partnering with policy makers, clinical and laboratory service providers, and community advocates.
The in-principle support of $1 million from the FHRI Fund Major Research Application Support program helped Dr Moore secure the NHMRC grant.
Activity Lead | Responsible Entity | Activity Title | External Program | MRAS funding awarded | Leveraged funding |
Associate Professor Hannah Moore | Curtin University | RISE: Modelling RSV Immunisation Strategies for Evidence-based policy |
NHMRC 2024 Partnership Projects PRC 3 |
$1,000,000 | $1,499,072.60 |